Daily funding & deals roundup: 6 stories curated September 6, 2026. Lead: Novartis India eyes therapy-aligned acquisition, Tier 2-3 market push.

The latest in funding & deals: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: Novartis India eyes therapy-aligned acquisition, Tier 2-3 market push.
Follow the full firehose on the HTC Wire, refreshed automatically every day.